Mouse myeloma cell line, NS0-derived human LAR protein
Ala27-Glu1251 with a C-terminal 6-His tag, and its proteolyzed forms Ala27-Arg1169 and Gln1170-Glu1251 with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ala27 and Gln1170

Predicted Molecular Mass

136 kDa

SDS-PAGE

114-146 kDa and 14 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human LRFN5 Fc Chimera (Catalog # 9385-SA) is used at 1 μg/mL, the concentration of Recombinant Human LAR that produces 50% optimal binding response is 1.5-9 μg/mL.

Scientific Data Images for Recombinant Human LAR Protein

Recombinant Human LAR Protein Bioactivity

When Recombinant Human LRFN5 Fc Chimera (Catalog # 9385-SA) is used at 1 µg/mL, 100 µL/well, Recombinant Human LAR (Catalog # 9377-PF) binds with an ED₅₀ of 1.5-9 µg/mL.

Formulation, Preparation and Storage

9377-PF

Formulation	Supplied as a 0.2 μm filtered solution in PBS.
Reconstitution	Reconstitution Buffer Available: Size / Price Qty Loading... RB01:
Shipping	The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after opening. 3 months, -20 to -70 °C under sterile conditions after opening.

Background: LAR

PTPRF (Receptor-type tyrosine-protein phosphatase F), also called LAR (Leukocyte common antigen related), is a 212 kDa single-pass type I membrane protein that is a member of the protein tyrosine phosphatase (PTP) family and the receptor class 2A subfamily (1). Human LAR cDNA encodes 1,907 amino acids (aa) including a 29 aa signal sequence, a 1234 aa extracellular region with six potential N-glycosylation sites, a 21 aa transmembrane sequence, and a 623 aa cytoplasmic domain (1). An 1,898 aa isoform appears from alternative splicing; it is missing aa 772 to 780 (1). Human LAR shares a 95% aa sequence identity with mouse and rat LAR. LARs have been shown to function in the regulation of epithelial cell-cell contacts at adherents junctions, as well as in the control of beta-catenin signaling (2). An increased expression level of LARs have been found in the insulin-responsive tissue of obese, insulin-resistant individuals, and may contribute to the pathogenesis of insulin resistance (3). LARs have been identified as novel ligands of SALM5/LRFN-5 that mediates SALM5/LRFN-5 dependent presynaptic differentiation in a splicing- dependent manner. SALM5/LRFN-5 interacts directly with the Ig domain of LAR family receptor protein tyrosine phosphatases. The postsynaptic SALM5/LRFN-5 promotes synapse development by trans-synaptically interacting with presynaptic LARs which is important for the regulation of excitatory synaptic strength (4). Clinically, LAR has been shown down-regulated in cancers and its up-regulation is associated with better clinical outcomes (5).

References

SwissProt Accession # P10586.
Um J.W. et al. (2013) Trends Cell Biol. 23:465.
Mander A. et al. (2005) FEBS Lett. 579:3024.
Choi, Y. et al. (2016) Sci Rep. 6:26676.
Bera, R. et al. (2014) Hepatology. 59:2238.

Long Name

Leukocyte Antigen-Related Tyrosine Phosphatase

Alternate Names

PTPRF

Entrez Gene IDs

5792 (Human); 104121 (Mouse)

Gene Symbol

PTPRF

UniProt

P10586-2

Additional LAR Products

Product Documents for Recombinant Human LAR Protein

Product Datasheets

Download Product Datasheets

COA

SDS

Download SDS

Product Specific Notices for Recombinant Human LAR Protein

For research use only

Citations
Reviews

Recombinant Human LAR Protein

R&D Systems, part of Bio-Techne | Catalog # 9377-PF

Key Product Details

Source

Accession #

Conjugate

Applications

View all LAR Proteins and Enzymes »

Product Specifications